117
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Nitration of H2B histone elicits an immune response in experimental animals

, , &
Pages 232-240 | Received 07 Jun 2016, Accepted 23 Jun 2017, Published online: 24 Jul 2017

References

  • Doyle HA, Aswad DW, Mamula MJ. Autoimmunity to isomerized histone H2B in systemic lupus erythematosus. Autoimmunity 2013;46:6–13.
  • Beckman JS, Beckman TW, Chen J, et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990;87:1620–1624.
  • Beckman JS, Ischiropoulos H, Zhu L, et al. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophys. 1992;298:438–445.
  • Shah D, Mahajan N, Sah S, et al. Oxidative stress and its biomarkers in systemic lupus erythematosus. J Biomed Sci. 2014;21:23.
  • Ohshima H, Friesen M, Brouet I, et al. Nitrotyrosine as a new marker for endogenous nitrosation and nitration of proteins. Food Chem Toxicol. 1990;28:647–652.
  • Ischiropoulos H. Protein tyrosine nitration – an update. Arch Biochem Biophys. 2009;484:117–121.
  • Munoz LE, van Bavel C, Franz S, et al. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus 2008;17:371–375.
  • Kurien BT, Scofield RH. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev. 2008;7:567–573.
  • Ahsan H, Ali A, Ali R. Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol. 2003;131:398–404.
  • Thuraisingham RC, Nott CA, Dodd SM, et al. Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int. 2000;57:1968–1972.
  • Mansour RB, Lassoued S, Gargouri B, et al. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand J Rheumatol. 2008;37:103–108.
  • Ben Mansour R, Lassoued S, Elgaied A, et al. Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies. Scand J Rheumatol. 2010;39:247–253.
  • Arents G, Moudrianakis EN. Topography of the histone octamer surface: repeating structural motifs utilized in the docking of nucleosomal DNA. Proc Natl Acad Sci U S A 1993;90:10489–10493.
  • van Holde KE. Chromatin. In: Rich A. editor. Springer series in molecular biology. New York, NY: Springer; 1989. p. 1–15.
  • Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293:1074–1080.
  • van Bavel CC, Dieker J, Muller S, et al. Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies. Mol Immunol 2009;47:511–516.
  • Dieker JW, van der Vlag J, Berden JH. Triggers for anti-chromatin autoantibody production in SLE. Lupus. 2002;11:856–864.
  • Burlingame RW, Rubin RL. Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin. J Clin Invest. 1991;88:680–690.
  • Rubin RL, Burlingame RW. Drug-induced autoimmunity: a disorder at the interface between metabolism and immunity. Biochem Soc Trans. 1991;19:153–159.
  • Rubin RL, Fritzler MJ. Antibodies to histones and nucleosome-related antigens. In: Wallace DJ, Hahn BH, editors. Dubois’ lupus erythematosus. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007. p. 394–400.
  • Fritzler MJ. Antibodies to histone and the role of the nucleosome. In: Wallace DJ, Hahn BH, editors. Dubois lupus erythematosus. 5th ed. Baltimore, MD: Williams & Williams; 1997. p. 423–441.
  • Koppenol WH, Kissner R, Beckman S. Syntheses of peroxynitrite: to go with the flow or on solid grounds? Methods Enzymol. 1996;269:296–302.
  • Khan MA, Alam K, Dixit K, et al. Role of peroxynitrite induced structural changes on H2B histone by physicochemical method. Int J Biol Macromol. 2016;82:31–38.
  • Khan MA, Dixit K, Moinuddin, et al. Studies on peroxynitrite-modified H1 histone: implications in systemic lupus erythematosus. Biochimie 2014;97:104–113.
  • Khan MA, Dixit K, Jabeen S, et al. Impact of peroxynitrite modification on structure and immunogenicity of H2A histone. Scand J Immunol. 2008;69:99–109.
  • Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;86:464–467.
  • Khan MA, Dixit K, Uddin M, et al. Role of peroxynitrite-modified H2A histone in the induction and progression of rheumatoid arthritis. Scand J Rheumatol. 2012;41:426–433.
  • Waris G, Khan MA, Khan S, et al. Binding of superoxide-modified DNA by cancer antibodies. J Exp Clin Cancer Res. 2007;25:499–504.
  • Dixit K, Khan MA, Sharma YD, et al. Peroxynitrite-induced modification of H2A histone mimics epitopes which are strongly bound by human anti-DNA autoantibodies: role of peroxynitrite-modified-H2A in SLE induction and progression. Hum Immunol. 2011;72:219–225.
  • Dixit K, Khan MA, Sharma YD, et al. Physicochemical studies on peroxynitrite-modified H3 histone. Int J Biol Macromol. 2010;46:20–26.
  • Drew B, Leeuwenburg C. Aging and the role of reactive nitrogen species. Ann N Y Acad Sci. 2002;959:66–81.
  • Oates JC, Gilkeson GS. The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Clin Immunol. 2006;121:243–250.
  • Khan MA, Dixit K, Arif Z, et al. Peroxynitrite-modified H3 histone is highly immunogenic and binds circulating SLE autoantibodies better than native DNA. Am J Biomed Sci. 2013;5:69–79.
  • Shacter E. Quantification and significance of protein oxidation in biological samples. Drug Metab Rev. 2000;32:307–326.
  • Beal MF. Oxidatively modified proteins in aging and disease. Free Radic Biol Med. 2002;32:797–803.
  • Souza JM, Peluffo G, Radi R. Protein tyrosine nitration – functional alteration or just a biomarker? Free Radic Biol Med 2008;45:357–366.
  • Crow JP. Measurement and significance of free and protein-bound 3-nitrotyrosine, 3-chlorotyrosine, and free 3-nitro-4-hydroxyphenylacetic acid in biologic samples: a high-performance liquid chromatography method using electrochemical detection. Methods Enzymol. 1999;301:151–160.
  • Oates JC, Christensen EF, Reilly CM, et al. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity. Proc Assoc Am Physicians. 1999;111:611–621.
  • Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med. 1994;120:227–237.
  • Ballestar E, Esteller M, Richardson BC. The epigenetic face of systemic lupus erythematosus. J Immunol. 2006;176:7143–7147.
  • Ahmad R, Ahsan H. Role of peroxynitrite modified biomolecules in the etiopathogenesis of systemic lupus erythematosus. Clin Exp Med. 2014;14:1–11.
  • Muller S, Isabey A, Cooppez M, et al. Specificity of antibodies raised against triacetylated histone H4. Mol Immunol. 1987;24:779–789.
  • Ghedira I, Landolsi H, Mankai A, et al. [Antihistones antibodies in systemic lupus erythematosus, comparison of three assays: ELISA, dot blot and immunoblot]. Pathol Biol (Paris). 2006;54:148–154.
  • Olins AL, Olins DE. Stereo electron microscopy of the 25-nm chromatin fibers in isolated nuclei. J Cell Biol. 1973;81:260–265.
  • Burlingame RW, Rubin RL, Balderas RS, et al. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest. 1993;91:1687–1696.
  • Burlingame RW, Boey ML, Starkebaum G. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest. 1994;94:184–192.
  • Losman MJ, Fasy TM, Novick KE, et al. Monoclonal autoantibodies to subnucleosomes from a MRL/MP(-)+/+ mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B and DNA. J Immunol. 1992;48:1561–1569.
  • Losman MJ, Fasy TM, Novick KE. Relationships among antinuclear antibodies from autoimmune MRL mice reacting with histone H2A-H2B dimers and DNA. Int Immunol. 1993;5:513–523.
  • Ahmad R, Ahsan H. Contribution of peroxynitrite, a reactive nitrogen species, in the pathogenesis of autoimmunity. In: Mavragani CP, editor. Autoimmune disorders – pathogenic aspects. Croatia: InTech Open Access Publishers; 2011. p. 141–156.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.